A Bitter Pill for Merck's Vioxx
A new study suggests a link between the popular painkiller and heart attacks, adding to concerns about the giant drugmaker
By Amy Barrett
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.